Kodiak Sciences Inc. (KOD) earnings date
Mar 30, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 44 days, typically, give or take 21 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | after close | 43 | 8-K |
| Q2 FY2026 | Thu, Aug 13, 2026 | after close | 44 | 8-K |
| Q1 FY2026 | Thu, May 7, 2026 | after close | 37 | 8-K |
| Q4 FY2025 | Tue, Mar 31, 2026 | after close | 90 | 8-K |
| Q3 FY2025 | Thu, Nov 13, 2025 | after close | 44 | 8-K |
| Q2 FY2025 | Wed, Aug 13, 2025 | after close | 44 | 8-K |
| Q1 FY2025 | Wed, May 14, 2025 | after close | 44 | 8-K |
| Q4 FY2024 | Thu, Mar 27, 2025 | after close | 86 | 8-K |
What they guided beta
| Q3 FY2026 | "“Looking ahead, we expect to announce the first Phase 3 KSI-101 results in December and, if successful, plan to file a BLA for KSI-101 in the second quarter of 2027." exhibit |
| Q3 FY2026 | "Phase 3 PEAK Study (KSI-101) – Pivotal Analysis 1 Topline Data Expected December 2026" exhibit |
| Q3 FY2026 | "Completion of enrollment in the second pivotal cohort evaluating 600 subjects across the PEAK and PINNACLE studies is expected in the fourth quarter of 2026, with topline clinical data release anticipated in the second quarter of 2027." exhibit |
| Q3 FY2026 | "Raised net proceeds of $69 million after the third quarter" exhibit |
| Q3 FY2026 | "Subsequent to September 30, 2026 , Kodiak raised aggregate net proceeds of $69 million from sales of common stock under its at-the-market (ATM) equity offering facility." exhibit |
| Q2 FY2026 | "Together, these efforts reflect our continued focus on disciplined execution as we advance our late-stage portfolio toward important clinical and regulatory milestones." Recent Business Highlights Phase 3 DAYBREAK Study — Topline Data Expected September 2026" exhibit |
| Q2 FY2026 | "Topline data for the one-year primary endpoint (Zenkuda and KSI-501) are expected in September 2026." exhibit |
| Q2 FY2026 | "Phase 3 PEAK Study – Pivotal Analysis 1 Topline Data Expected December 2026" exhibit |
| Q2 FY2026 | "Topline data from Pivotal Analysis 1 are expected in December 2026." exhibit |
| Q2 FY2026 | "Completion of enrollment in the second pivotal cohort evaluating 600 subjects across PEAK and PINNACLE supporting Pivotal Analysis 2 is expected in the fourth quarter of 2026, with topline data anticipated in the second quarter of 2027." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/KOD
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/KOD
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/KOD/"><img src="https://veritasdata.dev/embed/KOD.svg" alt="KOD earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/KOD/)
Script
<script async src="https://veritasdata.dev/embed/KOD.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/KOD"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.